Allergan launches new product in Refresh line

Article

Refresh Optive Advanced Preservative-Free Lubricant Eye Drops from Allergan features the same formula as Refresh Optive Advanced but without a preservative.

 

Irvine, CA-Allergan, Inc. announced the launch of Refresh Optive Advanced Preservative-Free Lubricant Eye Drops. Refresh Optive Advanced Preservative-Free features the same formula that works on all three layers of the tear film to relieve dry eye symptoms as Refresh Optive Advanced but without the use of a preservative.

Refresh Optive Advanced Preservative-Free stabilizes the lipid layer to help reduce tear evaporation, hydrates the aqueous layer, and provides an advanced lubricating and protective shield to the mucin layer, while further protecting epithelial cells from hypertonic stress.

 

Some lipid-enhanced tears contain up to 2.0 uL of lipid per drop, which is up to 33 times more lipid than that found in a normal tear film. Refresh Optive Advanced Preservative-Free delivers <0.1uL of lipid per drop to stabilize the lipid layer and restore the lipid that has been lost while delivering an optimized amount for increased tolerability, according to the company.

Refresh Optive Advanced Preservative-Free is available in 30 count single-use vials and a preserved multi-dose formula. Both may be used in combination with dry eye prescription therapies and do not require shaking prior to use. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
© 2025 MJH Life Sciences

All rights reserved.